Restoring longevity haircare


The scientific path to fuller hair.

Tomorrowlabs has been researching genetic hair loss for years. It’s an issue that affects both men and women, often at a young age. Our goal was to find a scientific answer to this hereditary problem.

We’ve succeeded with our Tomorrowlabs Hair Restoration series. Bringing longevity research to the field of advanced haircare it is based on our patent-pending HSF technology.
View products in store

0.1. Nutrient supply as the key to great hair.

In 2019, the Nobel Prize in Medicine was awarded for the discovery of the regenerative cell signal, HIF.

HIF plays an important role in the optimal supply of nutrients to the hair follicles. A sufficient supply of nutrients is an important prerequisite for longer hair growth cycles and enables already shrunken hair to grow back stronger and longer.

0.2. Effective treatment has to start early.

The cellular regenerative mechanism HIF gets inactivated by age and stress. As a result, hair follicles are increasingly ill-supplied with necessary nutrients.

Depending on hormonal factors, the blood vessels that supply the growing hair can no longer perform their task effectively. This results in the hair growing back thinner each time. At some point, it falls out completely. This cycle continues until the hair follicle dies.

Effective treatment must therefore start early, while the hair follicle is still alive and can recover. This insight inspired the development of the Tomorrowlabs Hair Restoration series that for the first time uses longevity research to address the issue of weak hair.

Tomorrowlabs | Hair Restoration Series

0.3. Tackling hereditary hair loss at its root.

Using the latest findings in Longevity science, Tomorrowlabs developed a proprietary ingredient, HSF, to protect and reactivate HIF and tackling hereditary hair loss at its root.

In a dermatologist-controlled clinical study, HSF has been shown to reduce or halt hair loss in 85% of the study participants suffering from alopecia, a maximum reduction of hair loss by 100%, and an average improvement of 65.72%. In hair model studies, HSF demonstrated its growth-promoting properties in an examination of the hair follicles³.

HSF combined with an active ingredient complex targets stem cells and fibroblasts in order to improve the important nutrient supply to the hair follicles and stimulate hair growth. This way, hereditary hair loss is tackled at its root.

0.4. Clinical results in patients with hair loss.

In a clinical investigation of 26 subjects with androgenetic alopecia, the active ingredient complex led to a clinically measurable increase in hair growth and reduction in hair loss after three months of daily use. Over the duration of the study, its effect on hair quantity, hair thickness, hair length, and the growth rate and duration of the hair growth phase (the anagen phase) was examined.

Overview of investigated parameters of the ingredient complex¹:

Increasing ratio of hair follicles in growth phase instead of resting phase
Positive effect on hair volume and quality
Reduction of hair loss
Increase in hair density
Satisfaction with the product
Excellent tolerance

0.5. Our Eyelash Booster for fuller eyelashes.

Scientific studies show that the active ingredient complex with HSF used in the Eyelash Booster helps eyelashes grow longer and stronger with results possible after only two weeks². We do not believe in the use of skin-irritating hormones. TThe technology behind the Eyelash Booster is an innovative skin-friendly alternative, which supports eyelash growth naturally through an improved nutrient supply.

0.6. Designed to optimize lash growth.

  • Designed for fuller lashes that appear thicker, stronger, and longer
  • Free of hormones prohibited by law and skin-friendly
  • Optimizes the growth phase of the hair follicles
  • First results can be visible after 14 days
  • Suitable for long term use
  1. Active ingredient complex consisting of GDHQG, EGCG2, glycine and zinc. Tested on 26 male volunteers between the ages of 18 and 70 with a hair loss level of III to IV determined on the Norwood Hamilton scale. The clinical study was randomized and double-blinded in 2014 by Induchem AG and all clinical observations were made under the supervision of a dermatologist.
  2. Tested in 2015 on 4 volunteers with 10% symrise sympeptidxlash measured with CANON 5-dmii after 2, 4, 6, and 8 weeks and daily one-time application.
  3. Bukowiecki J. et al. "HIF-1α stimulators function equally to leading hair loss agents in enhancing dermal papilla growth" Under Review in Skin Pharmacology and Physiology